Apidra and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apidra (insulin glulisine recombinant) and Zolpidem (zolpidem tartrate). Common drug interactions include hyperglycaemia among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Apidra and Zolpidem. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Apidra?

Apidra has active ingredients of insulin glulisine recombinant. It is often used in diabetes. eHealthMe is studying from 10,548 Apidra users. Check the latest studies of Apidra.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.



On Aug, 12, 2026

77 people who take Apidra and Zolpidem together, and have interactions are studied.

Apidra and Zolpidem drug interactions.

What are the common drug interactions of Apidra and Zolpidem, by gender? *:

female:

  1. Hyperglycaemia (high blood sugar)
  2. Hypertension (high blood pressure)
  3. Oedema (fluid collection in tissue)
  4. Pneumonia
  5. Renal failure acute (rapid kidney dysfunction)
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Blood glucose increased
  9. Breast cancer
  10. Delirium (wild excitement)

male:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. White blood cell count increased
  3. General physical health deterioration (weak health status)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Sedation
  6. Blood glucose increased
  7. Chronic kidney disease
  8. Gout (uric acid crystals building up in the body)
  9. Renal failure (kidney dysfunction)
  10. Abdominal distension

What are the common drug interactions of Apidra and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abnormal dreams
  2. Sleep terror (felling of terror in sleep)

30-39:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)

40-49:

  1. Back pain
  2. Blood creatinine increased
  3. Blood urea increased
  4. Burning sensation
  5. Cervicobrachial syndrome (pain in neck and arm with changing location)
  6. Confusional state
  7. Cough
  8. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  9. Dizziness
  10. Drug withdrawal convulsions

50-59:

  1. Haematochezia (passage of stools containing blood)
  2. Angina bullosa haemorrhagica (a condition of the mucous membranes characterized by the sudden appearance of one or more blood blisters within the oral cavity)
  3. Gingival bleeding (bleeding gums)
  4. Platelet count decreased
  5. Thrombocytopenia (decrease of platelets in blood)
  6. White blood cell count increased
  7. Glycosylated haemoglobin increased
  8. Chronic kidney disease
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Renal failure (kidney dysfunction)

60+:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Asthenia (weakness)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cardiac failure congestive
  5. Chest pain
  6. Chronic kidney disease
  7. Diabetic coma
  8. Dyspnoea (difficult or laboured respiration)
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. High Blood Pressure: 19 people, 24.68%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 19.48%
  3. Stress And Anxiety: 10 people, 12.99%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 10 people, 12.99%
  5. Depression: 9 people, 11.69%
  6. Pain: 8 people, 10.39%
  7. Asthma: 8 people, 10.39%
  8. Blood Pressure Abnormal: 8 people, 10.39%
  9. Abdominal Pain Upper: 8 people, 10.39%
  10. Type 2 Diabetes: 7 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Apidra and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Apidra and Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Apidra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apidra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on insulin glulisine recombinant and zolpidem tartrate (the active ingredients of Apidra and Zolpidem, respectively), and Apidra and Zolpidem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: